Table 1.
Demographic and Clinical Characteristics of the 2 Groups of Patients Assessed for CAC
| CAC score=0 (n=39) | CAC score >0 (n=43) | P value | |
|---|---|---|---|
| Age (years) | 49.0±8.9 | 57.7±10.2 | <0.001 |
| Sex (male %) | 20 (51.3) | 34 (79.1) | 0.01 |
| Hypertension (%) | 8 (20.5) | 14 (32.6) | 0.22 |
| Hyperlipidemia (%) | 17 (43.6) | 20 (46.5) | 0.80 |
| Smoking (%) | 1 (2.6) | 5 (11.6) | 0.12 |
| Overweight and obesity (%) | 24 (61.5) | 35 (81.4) | 0.05 |
| SBP (mmHg) | 119.0±15.7 | 121.4±15.7 | 0.50 |
| DBP (mmHg) | 76.5±10.4 | 78.3±9.9 | 0.43 |
| HR (beats/min) | 71.7±15.8 | 71.2±14.9 | 0.90 |
| BMI (kg/m2) | 26.9±4.8 | 28.8±4.3 | 0.09 |
| Medications | |||
| RAAS inhibitor (%) | 2 (5.1) | 7 (16.3) | 0.53 |
| β-blocker (%) | 10 (25.6) | 11 (25.6) | 0.99 |
| CCB (%) | 4 (10.3) | 7 (16.3) | 0.68 |
| Statin (%) | 12 (27.9) | 10 (25.6) | 0.82 |
| Leukocytes (109/L) | 6.2±1.1 | 6.9±2.5 | 0.09 |
| Glucose (mg/dl) | 100.0±13.9 | 95.1±9.4 | 0.21 |
| Sodium (mmol/L) | 140.2±1.9 | 140.4±1.4 | 0.76 |
| Potassium (mmol/L) | 4.4±0.3 | 4.3±0.3 | 0.37 |
| Creatinine (mg/dl) | 0.95±0.17 | 1.03±0.21 | 0.10 |
| TC (mg/dl) | 208.8±40.9 | 211.5±48.5 | 0.84 |
| TG (mg/dl) | 155.1±151.0 | 163.8±97.0 | 0.82 |
| HDL-C (mg/dl) | 57.8±19.2 | 55.6±12.8 | 0.64 |
| LDL-C (mg/dl) | 126.9±40.9 | 124.7±44.3 | 0.86 |
| hsCRP (mg/L) | 2.1±1.8 | 2.0±1.9 | 0.44 |
| eGFR (ml/min) | 101.5±13.4 | 94.9±18.9 | 0.08 |
BMI, body mass index; CAC, coronary artery calcium; CCB, calcium-channel blocker; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL-C, serum high-density lipoprotein cholesterol; HR, heart rate; hsCRP, high-sensitivity C-reactive protein; LDL-C, serum low-density lipoprotein cholesterol; RAAS, renin-angiotensin-aldo- sterone system; smoking, current smokers; SBP, systolic blood pressure; TC, serum total cholesterol; TG, serum triglycerides.